| Atrazine transforming polymer prepared by molecular imprinting with post-imprinting process. | |
| | |
MedLine Citation:
|
PMID: 17268641 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Molecularly imprinted polymers bearing atrazine transforming activity were prepared by using newly designed templates that are atrazine analogues attached with an allyl or a styryl group via a disulfide bond at the 6-position, methacrylic acid as a functional monomer and styrene/divinylbenzene as crosslinkers. After polymerization, the disulfide bond was reduced to remove the atrazine moiety from the polymer matrix, followed by oxidation of the remaining thiol group to generate sulfonic acid (post-imprinting treatment), so that both a methacrylic acid residue and a sulfonic acid residue existed in an atrazine-imprinted cavity. The polymers indicated the selective binding of triazine herbicides and catalytic activity for methanolysis at the 6-position of atrazine, yielding a low toxic atraton. |
| | |
Authors:
|
Takehisa Yane; Hideyuki Shinmori; Toshifumi Takeuchi |
Publication Detail:
|
Type: Journal Article Date: 2006-11-08 |
Journal Detail:
|
Title: Organic & biomolecular chemistry Volume: 4 ISSN: 1477-0520 ISO Abbreviation: Org. Biomol. Chem. Publication Date: 2006 Dec |
Date Detail:
|
Created Date: 2007-02-01 Completed Date: 2007-03-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101154995 Medline TA: Org Biomol Chem Country: England |
Other Details:
|
Languages: eng Pagination: 4469-73 Citation Subset: - |
Affiliation:
|
Graduate School of Science and Technology, Kobe University, Kobe 657-8501, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Towards organo-click reactions: development of pharmaceutical ingredients by using direct organocata...
Next Document: Synthesis, crystal structure and biological activity of beta-carboline based selective CDK4-cyclin D...